Home › Onxeo S.A.: Phase II trial results of Validive presented at the ASCO Conference
 

Keywords :   


Onxeo S.A.: Phase II trial results of Validive presented at the ASCO Conference

2015-04-02 18:23:24| Logistics - Topix.net

Regulatory News: Onxeo S.A. , an innovative company specializing in the development of orphan oncology drugs, today announced that Validive phase II clinical trial results have been accepted for a poster presentation at the 2015 Annual Meeting of the American Society of Clinical Oncology . The ASCO annual meeting is a major event in the field of oncology that brings together 30,000 health professionals and updates on the major latest steps and results achieved in oncology worldwide.

Tags: the results presented trial

Category:Transportation and Logistics

Latest from this category

All news
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
Transportation and Logistics »
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »